BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5555849)

  • 1. Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report.
    Rabhan NB; Kopf AW
    Arch Dermatol; 1971 Jun; 103(6):615-22. PubMed ID: 5555849
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970.
    Lever WF
    Arch Dermatol; 1972 Oct; 106(4):491-7. PubMed ID: 4562487
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.
    MacGregor RR; Sheagren JN; Lipsett MB; Wolff SM
    N Engl J Med; 1969 Jun; 280(26):1427-31. PubMed ID: 4306760
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate-day corticosteroid regimen.
    Haim S; Benderly A; Shafrir A; Levy J
    Dermatologica; 1971; 142(3):171-6. PubMed ID: 5112615
    [No Abstract]   [Full Text] [Related]  

  • 6. An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
    Chaidemenos GCh; Mourellou O; Koussidou T; Tsatsou F
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1386-91. PubMed ID: 17958846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
    Heaphy MR; Albrecht J; Werth VP
    Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood pemphigus treated with gold.
    Paltzik RL; Laude TA
    Arch Dermatol; 1978 May; 114(5):768-9. PubMed ID: 348118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pemphigus vulgaris with methotrexate.
    Lever WF; Goldberg HS
    Arch Dermatol; 1969 Jul; 100(1):70-8. PubMed ID: 5822360
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid.
    Krain LS; Landau JW; Newcomer VD
    Arch Dermatol; 1972 Nov; 106(5):657-61. PubMed ID: 4635797
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of prednisone intake in pemphigus vulgaris patients with the use of simple laboratory methods.
    Segal R; Maayan R; Kaufman H; Feuerman EJ
    J Am Acad Dermatol; 1987 Oct; 17(4):612-5. PubMed ID: 3668007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of cyclosporin in the treatment of pemphigus vulgaris. Apropos of 3 cases].
    Castro-Salomó A; Porcel JM; Ordi J; Martínez-Costa X; Vilardell M; Vidal J
    Med Clin (Barc); 1991 Apr; 96(16):619-20. PubMed ID: 2051832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
    Murdock DK; Lookingbill DP
    Arch Dermatol; 1990 Jan; 126(1):27-8. PubMed ID: 2105086
    [No Abstract]   [Full Text] [Related]  

  • 15. Disseminated superficial porokeratosis in patients with pemphigus vulgaris treated with steroids.
    Feuerman EJ; Sandbank M
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):59-61. PubMed ID: 294099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasma-like forms and immunofluorescent antibodies in cytoplasm and intercellular spaces of rete malpighii in pemphigus vulgaris and pemphigus vegetans.
    Grace AW
    Acta Cytol; 1969 Mar; 13(3):169-77. PubMed ID: 4890431
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity in patients with less than pemphigus vulgaris greater than before, during and after prolonged treatment with steroids.
    Shohat B; David M; Feuerman EJ
    Biomedicine; 1981 Jul; 35(3):101-3. PubMed ID: 6974011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical responsiveness after alternate-day corticosteroid therapy.
    Ackerman GL; Nolsn CM
    N Engl J Med; 1968 Feb; 278(8):405-9. PubMed ID: 5636662
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypophysoadrenal effects of prolonged corticotherapy in small doses in asthmatic patients].
    Magnenat G; Cruchaud S; Ruedi B
    Schweiz Med Wochenschr; 1972 Jun; 102(23):804-9. PubMed ID: 4338343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Post-mortem evaluation in endemic pemphigus foliaceus and pemphigus vulgaris].
    Aki HE; Sotto MN; Sampaio SA
    Med Cutan Ibero Lat Am; 1984; 12(2):151-7. PubMed ID: 6374324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.